Skip to content

Clinical Observation of Warm Acupuncture Combined with Bupi Peiyuan Zhiqiu Decoction in Treating Allergic Rhinitis with Deficiency of Spleen Qi in the real word

Clinical Observation of Warm Acupuncture Combined with Bupi Peiyuan Zhiqiu Decoction in Treating Allergic Rhinitis with Deficiency of Spleen Qi in the real word

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2200006503
Enrollment
Unknown
Registered
2022-08-16
Start date
2022-08-15
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic Rhinitis

Interventions

Treatment group:Conventional western medicine treatment+ Warm Acupuncture Combined with Bupi Peiyuan Zhiqiu Decoction
control group:Conventional western medicine treatment

Sponsors

Hospital of Chengdu University of traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 70 Years

Inclusion criteria

Inclusion criteria: ? It complies with the western medicine diagnostic standard for allergic rhinitis formulated by the Editorial Committee of the Chinese Journal of Otorhinolaryngology and the Chinese medicine diagnostic standard for otorhinolaryngology (ZY / T 001.6-94) issued by the State Administration of traditional Chinese medicine. ? The age and sex of patients are not limited; ? Patients had good compliance and were willing to participate in the trial; ? The patient has clear consciousness and can cooperate with examination and treatment; ? After carefully reading the informed consent form, the subjects are willing to participate in the study and sign the informed consent form

Exclusion criteria

Exclusion criteria: ???????????????????????? ?????????????????????. ? Those who fail to meet the inclusion criteria, fail to cooperate with the completion of data collection and have incomplete data; ? Patients who did not sign informed consent or participate in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Total score of nasal symptoms (TNSS);

Secondary

MeasureTime frame
Visual analog scale(VAS);Self made TCM syndrome score table;Drug score;Rhinocoujunctivitis Quality of Life Questionaire(RQLQ);

Countries

China

Contacts

Public ContactMingjun Jiang
1620558850@qq.com19983553323

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026